This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Diffuse Large B-Cell Lymphoma

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Diffuse Large B-Cell Lymphoma Means

Diffuse large B-cell lymphoma (DLBCL) is a cancer that starts in B cells, a type of white blood cell important for fighting infections. It is the most common form of non-Hodgkin lymphoma (NHL), a group of cancers that begin in the lymphatic system. DLBCL is called “diffuse” because the cancer cells spread widely through the lymph node tissue, and “large B-cell” because the cancer cells look larger than normal under a microscope. This lymphoma usually grows quickly and can form tumors in lymph nodes or other organs such as the spleen, liver, or bone marrow.

DLBCL can occur at any age but is more common in older adults. Symptoms often include swollen lymph nodes, fever, night sweats, unexplained weight loss, and feeling very tired. Because it can affect many parts of the body, symptoms vary depending on where the lymphoma is growing.

Why Diffuse Large B-Cell Lymphoma Matters in Cancer Care

DLBCL is an aggressive lymphoma, meaning it tends to grow and spread quickly if not treated. However, many patients respond well to treatment, which usually includes chemotherapy combined with targeted drugs that help the immune system attack cancer cells. Newer treatments, such as CAR T-cell therapy, are available for some patients whose lymphoma returns or does not respond to initial treatments.

Understanding the specific type of lymphoma is important because it guides treatment choices and helps predict how the disease might behave. DLBCL is part of a larger group of B-cell lymphomas, each with different features and treatment options. Talking with the healthcare team about the exact diagnosis and treatment plan is key to managing the disease.

What Patients Might See or Hear About DLBCL

Patients may hear the term “diffuse large B-cell lymphoma” in medical reports, during doctor visits, or when discussing treatment options. They might also encounter related terms like “non-Hodgkin lymphoma,” “B-cell lymphoma,” or names of specific treatments such as chemotherapy drugs or immunotherapies like CAR T-cell therapy.

Because DLBCL can be aggressive, patients might be told about the need for prompt treatment. They may also learn about symptoms to watch for and the importance of follow-up care. It’s normal to have questions about what the diagnosis means, how treatment works, and what side effects to expect.

How Doctors Use the Term in Diagnosis and Treatment

Doctors diagnose DLBCL by taking a biopsy, which means removing a small piece of tissue from a swollen lymph node or tumor. A pathologist examines the tissue under a microscope to confirm the type of lymphoma. Additional tests may check how far the lymphoma has spread and whether it has certain markers that affect treatment choices.

Treatment plans are based on the lymphoma’s subtype, stage, and the patient’s overall health. Common treatments include chemotherapy combined with targeted antibodies. For some patients, especially those whose lymphoma returns or does not respond to initial therapy, newer treatments like CAR T-cell therapy may be considered. These therapies use the patient’s own immune cells, modified in a lab to better attack lymphoma cells.

What Diffuse Large B-Cell Lymphoma Does Not Automatically Mean

Hearing the term DLBCL does not give a full picture of an individual’s health or treatment outcome. The diagnosis alone does not predict how well a person will respond to treatment or what side effects they might have. DLBCL includes many subtypes that differ in behavior and treatment response, so it’s important not to assume all cases are the same.

Also, the term does not mean that treatment will be the same for everyone. Each person’s care plan is personalized based on many factors, including age, overall health, and specific features of the lymphoma.

Common Questions to Ask Your Care Team

Patients and caregivers may find it helpful to ask questions such as: What subtype of DLBCL do I have? What stage is the lymphoma? What treatment options are available and what are their goals? What side effects should I expect? How will we know if the treatment is working? Are there clinical trials or newer treatments I should consider? What support services are available to help me through treatment?

Reading the Term in Context and Next Steps

When you see “diffuse large B-cell lymphoma” in a medical report or hear it from your doctor, it’s important to ask how it applies to your specific case. This term describes a group of related cancers, but your care team will explain what it means for your health and treatment. Understanding your diagnosis helps you make informed decisions and prepare for your care journey.

This information is educational and not a substitute for medical advice. Always talk with your healthcare providers about your diagnosis, treatment options, and any concerns you have. They can provide guidance tailored to your situation and help you navigate your care.

Sources

Public source information used for this glossary entry includes: